On-Site Home Hemodialysis With NxStage® For Skilled Nursing Facilities
What is On-Site Home Hemodialysis?
On-Site Home Hemodialysis (HHD) is a growing care model involving partnerships between Skilled Nursing Facilities (SNFs) and dialysis providers to offer in-house treatments at the SNF for residents requiring dialysis.
Watch the videos below to learn more.
A Growing Opportunity
End-Stage Renal Disease (ESRD) Patient Population in Nursing Homes
There are over 520,000 dialysis patients in the United States and approximately 65,000 of them reside in Skilled Nursing Facilities annually.1 By 2025, the population of dialysis patients is anticipated to grow to 700,000.1,2
Challenges with the current dialysis care model at SNFs have supported the growing movement towards a more patient-centric approach.
Dialysis residents that receive traditional off-site in-center hemodialysis treatments may struggle with hemodynamic or cardiovascular instability associated with longer, conventional hemodialysis treatments.
Conventional hemodialysis at a dialysis center may also be associated with longer post-dialysis recovery times and lower energy levels, which can cause dialysis residents to miss meals, rehabilitation, and social activities.10
Residents being treated at a dialysis center will likely require round-trip transportation three times a week to their clinic. This can be stressful for them and costly for SNFs. Economic challenges to consider when managing dialysis residents include:
Average roundtrip cost of transportation
Hours spent scheduling, coordinating, and transporting
SNFs are looking for unique competitive differentiator services to potentially improve occupancy and referrals.
The complex care required by SNF dialysis residents can result in organizational, staffing, scheduling, and communication difficulties between the SNF and the dialysis clinic. When transportation is added to the equation, a three-way communication challenge presents itself, increasing the possibility for confusion, delays, and/or schedule changes. When a dialysis resident’s schedule is compromised, they may miss meals or scheduled medications, which is detrimental to their health and wellbeing.
On-Site HHD - A Care Model for Success
On-Site HHD offers SNF patients requiring dialysis the opportunity to receive treatments on-site at the SNF where they reside.
Benefits of On-Site HHD
On-Site HHD minimizes the need for transportation to off-site dialysis treatments, usually at least three times per week.
Residents performing more frequent HHD on-site in a SNF have shown improvements in both survival and hospitalizations.4 In addition, more frequent hemodialysis in the general population is associated with:
Less risk of cardiovascular hospitalizations5
Improved post-dialysis recovery time6
More energy & vitality7
Reduced antihypertensive medications8
Improved survival9
In addition, a SNF On-Site HHD program allows a SNF the potential to increase referrals as well as decrease dialysis-related transportation expenses.3,10
Effective Care Partnerships
Effective programs rely on strong partnerships between dialysis providers and SNFs. Below are some roles and responsibilities to consider.
With over 11,000 patients worldwide in the home environment,11 the NxStage HHD system is the practical dialysis therapy for the SNF environment.
NxStage provides individualized treatment options to meet the clinical needs of patients, which may translate to success maintaining rehabilitation, medication, meal, and activity schedules.
Designed for Success
NxStage is the Practical Solution for On-Site HHD
NxStage offers the following advantages over traditional equipment in a SNF setting, including:
Minimizes requirements for plumbing and electrical alterations
Eliminates chemical disinfection cycles
Minimal changes required to existing plumbing and electrical wiring
Eliminates maintenance of RO water treatment
Lowers utility costs12,13
Smaller treatment space
Resource Center
Additional information on the benefits of Skilled Nursing Facility on-site home hemodialysis.
Despite the health benefits that more frequent home hemodialysis may provide to those with chronic kidney disease, this form of therapy is not for everyone.
The reported benefits of home hemodialysis may not be experienced by all patients.
The NxStage System One is a prescription device and, like all medical devices, involves some risks. The risks associated with hemodialysis treatments in any environment include, but are not limited to, high blood pressure, fluid overload, low blood pressure, heart-related issues, and vascular access complications. The medical devices used in hemodialysis therapies may add additional risks including air entering the bloodstream, and blood loss due to clotting or accidental disconnection of the blood tubing set. When vascular access is exposed to more frequent use, infection of the site, and other access related complications may also be potential risks. Patients should consult with their doctor to understand the risks and responsibilities of home and/or more frequent hemodialysis using the NxStage System One.
Patients and providers are encouraged to contact their state regulators to discuss state-specific regulations that may impact dialysis in the Skilled Nursing Facility setting.
References:
2019 USRDS Annual Data Report Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2015.
DataDialysis.org. FY2017 Dialysis Facility Report Data. 3. Yang A, Lee WY, Hocking K, Xelay Acumen, Inc., Affiliated Dialysis. Survival comparison of daily home hemodialysis vs conventional dialysis in the nursing home setting. Nephrology News & Issues. February 17, 2015.
Data on File. NxStage Medical, Inc. Health Advances Interviews. March 2020. Based on interviews with 9 facilities.
Weinhandl E, Hocking K, Markovich S, Vavrinchik S, Collins A. Increased Hemodialysis Frequency is Associated With Improved Clinical Outcomes Among Patients in Skilled Nursing Facilities. Abstract presented at ASN 2018.
Weinhandl ED, Nieman KM, Gilbertson DT, Collins AJ. Hospitalization in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients. Am J Kidney Dis., 2015;65(1):98-108.
Jaber BL, Lee Y, Collins AJ, et al. Effect of daily hemodialysis on depressive symptoms and post dialysis recovery time; interim report from the FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements) Study. Am J Kidney Dis. 2010;56(3);531-539.
Finkelstein FO, Schiller B, Daoul R, et al. At-home short daily hemodialysis improves the long-term health-related quality of life. Kidney Int. 2012;82(5);561-569.
FHN Trial Group. In-center hemodialysis six times per week versus three times per week. N Engl J Med. 2010;363(24);2287-2300.
Weinhandl ED, Liu J, Gilbertson DT, Ameson TJ, Collins AJ. Survival in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients. J Am Soc Nephrol. 2012;23(5);895-904.dol:10.1681/ASN.2011080761.
Data on file. NxStage Medical, Inc. Healthcare Advances Interviews. May 2013. Based on interviews with 5 facilities.
Data on File. NxStage Medical, Inc. July 2020.
In-center water calculations based on 500 mL/min DFR, 220 minute treatment, 109 L of dialysate per treatment, 3 treatments per week. This simulation uses a 3:1 ratio for RO systems
Home hemodialysis calculations based on 190 mL/min DFR, 30 L, 158 minute treatment, 30L of dialysate per treatment, 5 treatments per week. This simulation uses a 1:1 ratio for DI systems
X
Fresenius Medical Care and NxStage Have Merged
Fresenius Medical Care has successfully completed its merger with NxStage Medical Inc. By strengthening our vertically integrated dialysis business, the merger supports our initiative of driving growth in the core business with innovation, better clinical outcomes through Care Coordination and improving the patient experience. For information about NxStage products and services please continue to use this website. To learn more about Fresenius Medical Care and the merger, visit the links provided.